dehydroabietic acid has been researched along with Hepatocellular Carcinoma in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Jun, H; ZeXin, Z | 1 |
| Chen, W; Ding, Y; Gu, W; Jiang, C; Wang, Z; Zhang, G | 1 |
2 other study(ies) available for dehydroabietic acid and Hepatocellular Carcinoma
| Article | Year |
|---|---|
Screening of pyroptosis-related genes influencing the therapeutic effect of dehydroabietic acid in liver cancer and construction of a survival nomogram.
Topics: Abietanes; Biomarkers, Tumor; Carcinoma, Hepatocellular; cdc25 Phosphatases; Cyclin A2; Early Detection of Cancer; Female; Gene Expression Profiling; Gene Expression Regulation, Neoplastic; Hep G2 Cells; Humans; Kaplan-Meier Estimate; Kinesins; Liver Neoplasms; Male; Nomograms; Pyroptosis | 2021 |
Dehydroabietic acid derivative QC2 induces oncosis in hepatocellular carcinoma cells.
Topics: Abietanes; Adenosine Triphosphate; Amino Acid Chloromethyl Ketones; Calpain; Carcinoma, Hepatocellular; Caspase 3; Caspase Inhibitors; Cell Death; Cell Line, Tumor; Cell Membrane; Cytoskeleton; Hepatocytes; Humans; Imidazoles; Indoles; Liver Neoplasms; Membrane Potential, Mitochondrial; Reactive Oxygen Species | 2014 |